NANOBIOTIX: Preclinical Data Presented at First AACR Virtual Special Conference on Radiation Science and Medicine Showed NBTXR3 Combo Overcomes Anti-PD-1 Resistance, Promotes Strong Abscopal Effect an
Go back to NANOBIOTIX: Preclinical Data Presented at First AACR Virtual Special Conference on Radiation Science and Medicine Showed NBTXR3 Combo Overcomes Anti-PD-1 Resistance, Promotes Strong Abscopal Effect an| Nanometrics, Inc. (NASDAQ: NANO) | Delayed: 35.33 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.33 | 52 Week High | $23.88 | |||
| Open | $34.26 | 52 Week Low | $12.50 | |||
| Day High | $35.33 | P/E | N/A | |||
| Day Low | $35.33 | EPS | $-0.61 | |||
| Volume | 9,709 | |||||
| (NASDAQ: NBTX) | Delayed: 5.90 +0.19 (3.33%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.71 | 52 Week High | $ | |||
| Open | $5.92 | 52 Week Low | $ | |||
| Day High | $5.99 | P/E | N/A | |||
| Day Low | $5.90 | EPS | $ | |||
| Volume | 1,386 | |||||
